SCHEMBL3963618

SCHEMBL3963618

COc1cc(OC)c(C(=O)NN)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.53
GAA P10253 3/20 0.53
ALDH1A1 P00352 6/20 0.51
KDM4E B2RXH2 3/20 0.51
HTR4 Q13639 4/20 0.49
HTR3E A5X5Y0 2/20 0.49
HTR3B O95264 2/20 0.49
HTR3A P46098 2/20 0.49
HTR3D Q70Z44 2/20 0.49
HTR3C Q8WXA8 2/20 0.49
SLC22A1 O15245 1/20 0.49
LMNA P02545 1/20 0.49
MPO P05164 1/20 0.49
CYP1A2 P05177 1/20 0.49
ADRA2A P08913 1/20 0.49
CYP2D6 P10635 1/20 0.49
DRD2 P14416 1/20 0.49
ADRA2C P18825 1/20 0.49
DRD4 P21917 1/20 0.49
HTR2A P28223 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6581077 0.91 CTSD (0.59) CTSDGAAALDH1A1KDM4EHTR4
SCHEMBL2479746 0.90 CTSD (0.57) CTSDGAAALDH1A1KDM4ELMNA
SCHEMBL28895552 0.87 CTSD (0.61) CTSDGAAALDH1A1KDM4ELMNA
SCHEMBL9072065 0.87 GAA (0.50) CTSDGAAALDH1A1KDM4EHTR4
SCHEMBL7751850 0.87 GAA (0.71) GAAALDH1A1HTR4HTR3EHTR3B
SCHEMBL23716794 0.85 CTSD (0.63) CTSDGAAALDH1A1KDM4ELMNA
SCHEMBL7797927 0.82 GAA (0.50) GAAALDH1A1KDM4ELMNAKMT2A
SCHEMBL3876555 0.80 GAA (0.53) GAAALDH1A1KDM4EKMT2AMAPT
SCHEMBL8900419 0.80 GAA (0.72) GAAALDH1A1KDM4ELMNAKMT2A
SCHEMBL3617721 0.78 ALDH1A1 (0.55) GAAALDH1A1KDM4EKCNH2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029685-A1 OXADIAZOLE AND THIADIAZOLE COMPOUNDS AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS NEUROSEARCH A/S (DK) 2010-02-04 US disclosed
US-20100029685-A1 OXADIAZOLE AND THIADIAZOLE COMPOUNDS AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS NEUROSEARCH A/S (DK) 2010-02-04 US disclosed
CN-101553486-A Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators NEUROSEARCH AS (DK) 2009-10-07 CN disclosed
EP-2079734-A1 OXADIAZOLE AND THIADIAZOLE COMPOUNDS AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS NeuroSearch A/S (DK) 2009-07-22 EP disclosed
WO-2008049864-A1 OXADIAZOLE AND THIADIAZOLE COMPOUNDS AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS NEUROSEARCH A/S (DK) 2008-05-02 WO disclosed
WO-2008049864-A1 OXADIAZOLE AND THIADIAZOLE COMPOUNDS AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS NEUROSEARCH A/S (DK) 2008-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029685-A1 OXADIAZOLE AND THIADIAZOLE COMPOUNDS AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS CHRNA3, CHRNA5, CHRNB3 CTSD 3366/4885GAA 4007/4885ALDH1A1 1090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.